• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
XGD
Click for more information
0.18% 8,892.2

S&P/ASX All Ordinaries Gold

watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
XGD
XGD Chart 		20/02/19 15 2.4K
20/02/19 Last post  sreeve Comments Created with Sketch.  15  Views Created with Sketch.  2.4K 
XGD
News: XGD Australia shares tumble on Wall Street slide; NZ ends at 3-week low 		06/02/18 0 343
06/02/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  343 
XGD
News: XGD Australian shares open the week in red; NZ falls 		05/02/18 0 200
05/02/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  200 
XGD
News: XGD Australia shares trim losses as materials gain; NZ at 2-week top 		25/01/18 0 289
25/01/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  289 
XGD
News: XGD Australia shares pressured by banks, Wall St; NZ up 		25/01/18 0 198
25/01/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  198 
XGD
News: XGD Australia shares flat as financials erode gains in materials; NZ up 		22/01/18 0 218
22/01/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  218 
XGD
News: XGD Australia shares edge lower as miners slide; NZ up 		19/01/18 0 230
19/01/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  230 
XGD
News: XGD Australian shares slip slightly on Wall Street pause; NZ little changed 		19/01/18 0 173
19/01/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  173 

See All Discussions arrow Created with Sketch.
(20min delay)
Last
8,892.2 		Change
-15.900(0.18%) 		Mkt cap ! n/a
Open High Low
8,908.1 8,924.2 8,857.7
XGD (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The market's shrugged at China's stimulus measures all year. Why is this one different? If you've been following the Chinese economy this year, you'd know that the country has been trying to stimulate all year.
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders Estrella has become the first foreign entity to win mining acreage in Timor-Leste under that country's new mining laws enacted in 2021.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.